An unusual presentation of adenoid cystic carcinoma of the minor salivary glands with cranial nerve palsy: a case study
© Abdul-Hussein et al; licensee BioMed Central Ltd. 2007
Received: 18 August 2006
Accepted: 13 August 2007
Published: 13 August 2007
Adenoid Cystic Carcinoma (ACC) is a rare tumor entity and comprises about 1% of all malignant tumor of the oral and maxillofacial region. It is slow growing but a highly invasive cancer with a high recurrence rate. Intracranial ACC is even more infrequent and could be primary or secondary occurring either by direct invasion, hematogenous spread, or perineural spread. We report the first case of the 5th and 6th nerve palsy due to cavernous sinus invasion by adenoid cystic carcinoma.
A 49-year-old African American female presented to the emergency room complaining of severe right-sided headache, photophobia, dizziness and nausea, with diplopia. The patient had a 14 year history migraine headaches, hypertension, and mild intermittent asthma. Physical examination revealed right lateral rectus muscle palsy with esotropia. There was numbness in all three divisions of the right trigeminal nerve. Motor and sensory examination of extremities was normal. An MRI of the brain/brain stem was obtained which showed a large mass in the clivus extending to involve the nasopharynx, pterygoid plate, sphenoid and right cavernous sinuses.
Biopsy showed an ACC tumor with a cribriform pattern of the minor salivary glands. The patient underwent total gross surgical resection and radiation therapy.
This is a case of ACC of the minor salivary glands with intracranial invasion. The patient had long history of headaches which changed in character during the past year, and symptoms of acute 5th and 6th cranial nerve involvement. Our unique case demonstrates direct invasion of cavernous sinus and could explain the 5th and 6th cranial nerve involvement as histopathology revealed no perineural invasion.
Adenoid Cystic Carcinoma (ACC) is a rare tumor entity and comprises about 1% of all malignant tumor of the oral and maxillofacial region . It is a slowly growing but highly invasive cancer with high recurrence rate. Lymphatic spread to local lymph nodes is rare. Hematogenous spread, however, occurs often in the course of the disease . Intracranial ACC even is more rare and has been reported as 4 – 22% of ACC . It could be primary or secondary which could occur either by direct invasion like in our case, hematogenous spread, or perineural spread [4, 5]. Perineural spread of ACC has long been recognized. The literature revealed that the region of Gasserian ganglion to be the most common site of involvement (35.8%) [2, 3, 6, 7], while cavernous sinus was involved in 15.1% [3–5, 8, 9]. Presenting signs and symptoms are related to the anatomical site of the lesion. Facial pain, parasthesia in trigeminal distribution is commonly reported reflecting the frequency of involvement of gasserian ganglia, and possibility of perineural spread along the trigeminal nerve. Involvement of cavernous sinus could be asymptomatic  or could present with involvement of either 3rd, 4th, 5th, 6th and internal carotid artery [8, 9]. Literature is consistent that the time between onset of neurological signs and symptoms, and the time of diagnosis range between few months to 3 years [3, 6, 7, 10]. However, one study suggests that the duration could be several years .
A 49-year-old African American female with a past medical history of hypertension, migraine headaches and mild intermittent asthma presented to emergency room with a severe right-sided headache for the last 3 days. The patient gave a 14-year history of migraine headaches described as a slow onset unilateral throbbing headaches without aura accompanied by nausea and lasting 2–3 days. The patient stated that her migraine attacks were decreasing in frequency and severity for the past 2–3 years until the past year when she started experiencing different kind of headache. At the time of examination, she described the headache as sharp, intermittent, non-radiating pain with sudden onset behind her right eye lasting 1–2 days. During the last 3 days the pain became more intense, reported as 10/10 on the pain scale 1 to 10, with associated photophobia, dizziness and nausea, with diplopia that was worsened with gaze to the right lateral field. Her past medical history was significant for hypertension and asthma which were stable. Her past surgical history is significant for adenoidectomy at age of 12. Her family history is significant for a sister with breast cancer, and a father who died of renal cancer. A complete review of systems was otherwise negative.
Our patient's course prior to diagnosis is unusual. The patient had a history of 14-year headaches which changed in character for the past year, and symptoms of acute 6th and 5th cranial nerve involvement. It is difficult to determine whether the 14-year history of headache was due to slowly growing ACC with gradual invasion of clivus, nasopharnx sphenoid, and cavernous sinus. It is possible that when the patient started experiencing "different" kind of headache was a warning sign of intracranial invasion of vital structures. This is likely due to the fact that ACC is a very slowly growing tumor [2, 7, 8], and the size of the patient's tumor was 3.8 × 3 × 2 cm. when discovered. In our case, direct invasion of cavernous sinus could explain 6th and 5th cranial involvement, as histopathology revealed no perineural invasion. Based on the literature review, there are only two other cases of intracranial ACC with 6th nerve involvement. One case was reported 6th nerve involvement due to perineural spread  and second case was duo to invasion of the cavernous sinus .
The prognostic factors of ACC depend on tumor site, tumor stage, the presence of perineural invasion, and tumor grade. Tubular and cribriform subtypes have better prognosis than solid subtypes [2, 11, 12]. Many authors describe worse prognosis for tumor of the minor salivary glands, due to early local infiltration and invasion of surrounding tissue and bone [13, 14] as in our reported case. The treatment of choice consists of total tumor resection [1–7, 10, 11]. However, there is still controversy regarding the adjuvant treatment of this tumor. Several authors recommend postoperative radiation since radiation often produces tumor regression and relieve symptoms [15–17]. Prokopakis and Kokemueller, on the other hand, doubt that postoperative radiation may influence the course of the disease [1, 18]. On the other hand, chemotherapy use for ACC is controversial. Some authors report it being ineffective  while others had some positive response and recommend chemotherapy as palliative treatment in advance cases of ACC .
We report a case of ACC arising from the minor salivary glands and invading the clivus nasopharynx, sphenoid, and cavernous sinuses. Controversy exists regarding the most effective treatment of ACC and there is lack of reliable information about the clinical behavior of ACC in response to treatment. Further clinical trials needed to evaluate the effectiveness of treatment on improving quality of life and survival rates. This case is a reminder that careful monitoring of headache symptoms in patients is essential and a change in characteristics should prompt further investigations.
Patients' consent was obtained for publication of this case report.
- Kokemueller H, Eckardt A, Brachvogel P, Hausamen J-E: Adenoid cystic carcinoma of the head and neck-a 20 years experience. Int J Oral Maxillofac Surg. 2004, 33: 25-31. 10.1054/ijom.2003.0448.View ArticlePubMedGoogle Scholar
- Huang MX, Ma D, Sun K, Yu G, Guo C, Gao F: Factors influencing survival rate in adenoid cystic carcinoma of the salivary glands. Int J Oral Maxillofac Surg. 1997, 26: 435-439. 10.1016/S0901-5027(97)80008-2.View ArticlePubMedGoogle Scholar
- Cargill H, Alleyne , Roy AE, Bakay , Donal C, Bill T, Greg Joseph: Intracranial adenoid cystic carcinoma. Case report and review of the literature. Surg Neurol. 1996, 45: 265-71. 10.1016/0090-3019(95)00235-9.View ArticleGoogle Scholar
- Laligam Sekhar, Chandra Sen, Hae Dong Jho, Ivo Janecka: Surgical treatment intracavernous neoplasms: a four – year experience. Neurosurgery. 1989, 24 (1): 18-30.View ArticleGoogle Scholar
- Morioka T, Matsushima T, Ikezaki K, Nagata S, Ohta M, Fukui M: Intracranial adenoid cystic carcinoma mimicking meningioma; report of two cases. Neuroradiology. 1993, 35: 462-465. 10.1007/BF00602833.View ArticlePubMedGoogle Scholar
- Dolan EJ, Schwartz ML, Lewis AJ, Kassel EE, Cooper PW: Adenoid cystic carcinoma, an unusual neurosurgery entity. Can J Neurol Sci. 1985, 12: 65-68.PubMedGoogle Scholar
- Wakisaka S, Nonaka A, Morita Y, Fukui M, Kinoshita K: Adenoid cystic carcinoma with intracranial extension: report of three cases. Neurosurgery. 1990, 26 (6): 1060-1065. 10.1097/00006123-199006000-00025.View ArticlePubMedGoogle Scholar
- Piepemeier J, Virapongse C, Kier E, Kim J, Geenberg A: Intracranial adenocystic carcinoma presenting as a primary brain tumor. Neurosurgery. 1983, 12 (3):Google Scholar
- Vincentelli F, Grisoli F, Leclercq TA, Ardaud B, Diaz-Vasquez P, Hassoun J: Cylindromas of the base of the skull. J Neurosurg. 1986, 65 (6): 856-859.View ArticlePubMedGoogle Scholar
- Jayalakshmi S, Agarwal S, Nachiappan PL, Prasad RR, Bhuthra S, Sharma MC, Julka PK: Intracranial adenoid cystic carcinoma, a case report. J Neuro-oncology. 2000, 47: 47-50. 10.1023/A:1006151724860.View ArticleGoogle Scholar
- Norberg-Spaak L, Dardick I, Ledin T: Adenoid cystic carcinoma: use of cell proliferation, BCL-2 expression, histologic grade, and clinical stage as predictors of clinical outcome. Head Neck. 2000, 22 (5): 489-497. 10.1002/1097-0347(200008)22:5<489::AID-HED8>3.0.CO;2-X.View ArticlePubMedGoogle Scholar
- Khan AJ, DiGiovanna MP, Ross DA, Sasaki CT, Carter D, Son YH, Haffty BG: Adenoid cystic carcinoma; a retrospective clinical review. Int J Cancer. 2001, 96: 149-158. 10.1002/ijc.1013.View ArticlePubMedGoogle Scholar
- Nascimento AG, Amaral ALP, Prado LAF, Kligerman J, Silveira TRP: Adenoid cystic carcinoma of salivary glands. A study of 61 cases with clinicopathological correlation. Cancer. 1985, 57: 312-319. 10.1002/1097-0142(19860115)57:2<312::AID-CNCR2820570220>3.0.CO;2-A.View ArticleGoogle Scholar
- Maso MD, Lippi L: Adenoid cystic carcinoma of the head and neck; a clinical study of 37 cases. Laryngoscope. 1985, 95: 177-181. 10.1288/00005537-198502000-00009.View ArticleGoogle Scholar
- Avery CME, Moody AB, McKinna FE, Taylor J, Henk JM, Langdon JD: Combined treatment of adenoid cystic carcinoma of the salivary glands. Int J OKral Maxillofac Surg. 2000, 29: 277-279. 10.1016/S0901-5027(00)80028-4.View ArticleGoogle Scholar
- Matsuba HM, Spector GJ, Thawley SE, Simpson JR, Mauney M, Pikul FJ: Adenoid cystic salivary glands carcinoma; a histopathological review of treatment failure patterns. Cancer. 1986, 57: 519-524. 10.1002/1097-0142(19860201)57:3<519::AID-CNCR2820570319>3.0.CO;2-V.View ArticlePubMedGoogle Scholar
- Miglianico L, Eshwege F, Marandas P, Wilbault P: Cervico-facial adenoid cystic carcinoma study of 102 cases. Influence of radiation therapy. Int J Radiat Oncol Biol Phys. 1987, 13 (5): 673-678.View ArticlePubMedGoogle Scholar
- Prokopakis EP, Snyderman CH, Hanna EY, Carrau RL, Johnston JT, D'Amico F: Risk factors for local recurrence of adenoid cystic carcinomas. Am J Otolaryngol. 1999, 20: 281-286. 10.1016/S0196-0709(99)90028-5.View ArticlePubMedGoogle Scholar
- Hill ME, Constenla DO, Hern JM, Gore ME: Cisplatin and 5-Fluorouracil for symptom control in advanced salivary adenoid cystic carcinoma. Oral Oncol. 1997, 33: 275-278.View ArticlePubMedGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2407/7/157/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.